Seeking physician quotes on congenital hearing loss care Looking for quotes from physicians, ENT, audiology, and pediatric specialists on how congenital hearing care has changed over the last decade, what devices still do best, and where biology-based approaches fit. Short quotes work. Answer as many or as few questions as your time permits. Questions What has been the biggest practical improvement in congenital hearing care in the last 10 years. What is one area where cochlear implants outperform expectations, and one area where limits remain clear. How much does etiology influence outcomes in your patient population, in your experience. What is one change you have made in your clinical workflow because genetic results are more accessible. What does “precision hearing care” mean to you in day-to-day practice. What would make biology-based therapy a routine referral, proof of durability, safety, ease of delivery, or something else. What should general pediatricians do differently when they get a newborn screen referral.

The biggest practical advancement over the last 10 years has been how the availability of universal newborn hearing screening, along with neuro-developmental protocols and improved access to household resources, has increased the number of children we can intervene for before a lasting language delay has occurred. Cochlear implants continuously outpace expectations for how children implanted early will develop phonological and spoken language abilities to a near-typical range. However, their extreme limitations are defined in noisy situations when the brain is unable to filter out a single voice from the background complexity of sound. The primary indicator of a child's success with implant technology is the cause of the hearing loss. The etiology of hearing loss is key to the child's ability to sufficiently integrate auditory input; children with non-syndromic genetic hearing losses can usually process more rapidly than children whose hearing loss is secondary to a congenital infection like Cytomegalovirus (CMV), which affects broader neural pathways. With increased access to genetic sequencing, I have redesigned my clinical practices to incorporate early neuropsychological standard testing for any child with a genetically confirmed mutation, allowing me time to categorically preempt any learning or social-emotional barriers. To me, precision hearing care is moving away from a blanket view of sensory loss and instead developing a definitive therapeutic and educational environment tailored specifically to the child's own molecular and neurological profile. Biology-based therapy will evolve into a standard referral once sufficient longitudinal evidence establishes that a single intervention can sustain the neural-to-hair-cell connections as the child's auditory system matures through the adolescent period. Pediatricians should treat every failed newborn hearing screen as a developmental emergency rather than adopting a "wait and see" approach, since even a few months of auditory deprivation can result in a host of measurable changes to how the brain organizes the sound and language continuum.